A novel comparative effectiveness study of Tai Chi versus aerobic exercise for fibromyalgia: study protocol for a randomized controlled trial by Chenchen Wang et al.
TRIALS
Wang et al. Trials  (2015) 16:34 
DOI 10.1186/s13063-015-0548-xSTUDY PROTOCOL Open AccessA novel comparative effectiveness study of Tai
Chi versus aerobic exercise for fibromyalgia: study
protocol for a randomized controlled trial
Chenchen Wang1*, Timothy McAlindon1, Roger A Fielding2, William F Harvey1, Jeffrey B Driban1, Lori Lyn Price3,
Robert Kalish1, Anna Schmid1, Tammy M Scott4 and Christopher H Schmid5Abstract
Background: Fibromyalgia is a chronic musculoskeletal pain syndrome that causes substantial physical and
psychological impairment and costs the US healthcare system over $25 billion annually. Current pharmacological
therapies may cause serious adverse effects, are expensive, and fail to effectively improve pain and function.
Finding new and effective non-pharmacological treatments for fibromyalgia patients is urgently needed. We are
currently conducting the first comparative effectiveness randomized trial of Tai Chi versus aerobic exercise
(a recommended component of the current standard of care) in a large fibromyalgia population. This article
describes the design and conduct of this trial.
Methods/design: A single-center, 52-week, randomized controlled trial of Tai Chi versus aerobic exercise is being
conducted at an urban tertiary medical center in Boston, Massachusetts. We plan to recruit 216 patients with
fibromyalgia. The study population consists of adults ≥21 years of age with fibromyalgia who meet American
College of Rheumatology 1990 and 2010 diagnostic criteria. Participants are randomized to one of four Tai Chi
intervention groups: 12 or 24 weeks of supervised Tai Chi held once or twice per week, or a supervised aerobic
exercise control held twice per week for 24 weeks. The primary outcome is the change in Revised Fibromyalgia
Impact Questionnaire total score from baseline to 24 weeks. Secondary outcomes include measures of widespread
pain, symptom severity, functional performance, balance, muscle strength and power, psychological functioning,
sleep quality, self-efficacy, durability effects, and health-related quality of life at 12, 24, and 52 week follow-up.
Discussion: This study is the first comparative effectiveness randomized trial of Tai Chi versus aerobic exercise in a
large fibromyalgia population with long-term follow up. We present here a robust and well-designed trial to
determine the optimal frequency and duration of a supervised Tai Chi intervention with regard to short- and long-term
effectiveness. The trial also explores multiple outcomes to elucidate the potential mechanisms of Tai Chi and aerobic
exercise and the generalizability of these interventions across instructors. Results of this study are expected to have
important public health implications for patients with a major disabling disease that incurs substantial health burdens
and economic costs.
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Fibromyalgia is a multidimensional complex disorder
characterized by chronic widespread musculoskeletal pain,
fatigue, sleep disturbance, and physical and psychological
impairment [1,2]. It is the second most common rheuma-
tologic condition, affecting up to 2% of the general popu-
lation between 18 and 65 years of age representing
approximately 10 million individuals in the US [1-4]. The
prevalence increases with age to 7% of individuals in their
seventh and eighth decades. As a result, fibromyalgia can
have devastating effects on quality of life with productivity
loss and increased healthcare costs [5-7].
Although marginal short-term benefits have been
found for several pharmacologic interventions, no satis-
factory long-term pharmacological therapies, including
analgesics and antidepressants, have been consistently
demonstrated [8-11]. Even with the recent approval of
three drugs by the Food and Drug Administration to
treat fibromyalgia symptoms, pharmacotherapy is often
insufficient to resolve persistent symptoms or improve
function and quality of life. Furthermore, these drugs are
expensive and carry a hidden cost of significant risk of
serious adverse events and cannot be tolerated by many
participants [10,12].
Since the 1970s, over 80 exercise interventions (65
randomized trials) in fibromyalgia have been published
with a total of 5,077 participants [13-20]. Aerobic exer-
cise (land and water) and its combinations are a com-
mon modality with treatment frequency of 2 to 3 times
per week. Most aerobic exercise studies reached their
adherence goals. Busch and colleagues assessed 34 stud-
ies with 2,276 participants and found that aerobic-only
exercise may have beneficial effects on pain [13]. Of the
10 studies from our meta-analysis, six reported that
short-term aerobic exercise may result in improvement
in subjective pain [15]. Consequently, moderate aerobic
exercise is currently recommended as part of standard
care for the management of fibromyalgia [8-11,13,21].
Previous trials have demonstrated that Tai Chi, a com-
plex multi-component mind-body intervention can im-
prove both physical health (aerobic cardiovascular
fitness, muscle conditioning, and flexibility) and mental
health (psychological well-being, life satisfaction, and
perceptions of health) in patients with chronic condi-
tions [22-31]. We have also shown that Tai Chi has great
therapeutic benefits for individuals with fibromyalgia
compared with a control intervention consisting of well-
ness education and stretching [32]. Furthermore, in re-
cent meta-analysis of seven studies in 391 participants,
we found that 6 to 12 weeks of Tai Chi practice im-
proved fibromyalgia symptoms (effect size 0.50, 95%
confidence interval (CI) 0.19 to 0.81), pain (effect size
0.45, 95% CI 0.24 to 0.66), and sleep quality (effect size
0.48, 95% CI 0.14 to 0.81), compared with a variety ofcontrols [33]. This preliminary evidence thus merits this
proposed long-term study with a larger clinical sample.
We are currently conducting the first comparative effect-
iveness trial of Tai Chi versus aerobic exercise in a large
symptomatic fibromyalgia population. We hypothesize
that: 1) participants receiving Tai Chi, as opposed to aer-
obic exercise, will have greater improvement in fibromyal-
gia symptom severity, musculoskeletal pain, fatigue and
sleep disturbance, physical and psychosocial functioning,
as well as health-related quality of life; 2) participants re-
ceiving higher frequency supervised Tai Chi (2 times per
week) will have greater improvement than those receiving
lower frequency supervised Tai Chi (once per week); 3)
participants receiving longer periods (24 weeks) of super-
vised Tai Chi will have greater improvement than those re-
ceiving shorter periods (12 weeks) of supervised Tai Chi;
and 4) participants who continue Tai Chi will have durable
benefits as determined over a 52-week follow-up period.
Overall, we aim to demonstrate that, compared with aer-
obic exercise, Tai Chi is a more effective intervention for
fibromyalgia and has clinical utility in a larger scale study
and over a longer period of time.
In this paper we present the design and detailed proto-
col of the first comparative effectiveness trial. Our design
is innovative in that it is the first comparative effectiveness
trial of fibromyalgia using regimens of Tai Chi and aerobic
exercise that would be practical and realistic for
generalization to real-world treatment by exploring the
dose response of Tai Chi therapy through a factorial ar-
rangement of instructor, duration, and frequency. The ul-
timate goal is to provide a cost-effective, complementary,
and integrative approach to the symptom management for
millions of individuals with fibromyalgia with limited
therapeutic options. It is expected that the study will fill
important knowledge gaps and generate critical insight to
inform clinical decision-making for chronic pain. The
results will be reported at the completion of the study in
accordance with the Consolidation of Standards for
Reporting Trials guidelines [34].
Methods/design
Study design overview
This study is a single-center, 52-week, randomized con-
trolled trial. Patients with fibromyalgia are randomized
to one of four Tai Chi intervention groups: 12 or
24 weeks of supervised Tai Chi held once or twice per
week, or a supervised aerobic exercise control twice per
week for 24 weeks. All groups will have a 52-week
follow-up. The primary outcome is the change in Re-
vised Fibromyalgia Impact Questionnaire (FIQR) total
score from baseline to 24 weeks [35].
Outcome measurements are collected at baseline,
every week during the intervention period (FIQR and
adverse events only), upon completion of the 12 or
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the physical function assessments and the statistician are
blinded to treatment assignment. The specific endpoints
and their conceptualization as outcomes or intermediar-
ies are presented in Table 1.
The study setting is an urban tertiary care academic hos-
pital, Tufts Medical Center, in Boston, Massachusetts,






Widespread Pain Index x
Symptom Severity Scale x
Participant Global Assessment x
Pittsburgh Sleep Quality Index x
Patients’ Global fibromyalgia Severity x
SF-36 x
Beck II Depression Inventory x
Perceived Stress Scale x
Chronic Pain Self-Efficacy x
Social Support Survey x
Coping Strategies Questionnaire x
MOS Social Support Survey x
OES for exercise x
OES for Tai Chi/AE x
PROMISb x
Health Assessment Questionnaire x
NEO Five-Factor Inventoryc x
Five Facet Mindfulness x
Credibility-Expectancyd x
Pre-clinical disability x
The Hospital Anxiety and Depression Scale x
CHAMPS activities x
Functional Performance Testse x
Body mass index x
Medications x
Adverse events x x
Adherence x x
aRevised Fibromyalgia Impact Questionnaire (FIQR) is the primary outcome at 24 we
Reported Outcomes Measurement Information System (PROMIS) questionnaires inc
PROMIS Anxiety, PROMIS Sleep Disturbance, Satisfaction with Social Roles, and PRO
out once over the course of the study at the earliest available evaluation period. dT
intervention session. eFunctional Performance Tests include timed chair stand, one
MOS, Medical Outcome Study; OES, Outcome Expectations Scale; SF-36, Medical Ou
Program for SeniorsMedical Center/Tufts University Institutional Review
Board (approval number 9945).Study sample
Patients who meet both American College of Rheuma-
tology 1990 and 2010 new criteria are eligible to partici-
pate in this study [36,37] (Table 2).ndary outcomes
tervention Week 12 Week 24 Week 52



























eks; the other collection times are secondary outcome variables. bParticipant-
lude PROMIS Pain Impact, PROMIS Physical Function, PROMIS Depression,
MIS Health Assessment Questionnaire. cThe NEO Five-Factor Inventory is given
he Credibility-Expectancy Questionnaire is given out before the start of the first
leg stand, 6-minute walk, and muscle strength and power. AE, aerobic exercise;
tcome Survey Short-Form 36; CHAMPS, Community Health Activities Model
Table 2 Eligibility criteria
Inclusion criteria Exclusion criteria
• Age 21 years or older • Prior experience with Tai Chi or other similar types of complementary
and alternative medicine in the past 6 months such as Qi Gong and
yoga since these share some of the principles of Tai Chi• Fulfills the American College of Rheumatology (ACR) 1990 classification
criteria for fibromyalgia: (1) a history of widespread musculoskeletal pain
on the right and left sides of the body as well as above and below the
waist for a minimum duration of 3 months, and (2) pain in 11 or more of
18 specific tender points with moderate or greater tenderness reported
upon digital palpation[35]
• Dementia, neurological disease, cancer, cardiovascular disease,
pulmonary disease, metabolic disease, renal disease, liver disease, or
other serious medical conditions limiting ability to participate in the Tai
Chi or aerobic exercise programs, as determined by primary care
physicians
• Fulfills the ACR 2010 diagnostic criteria for fibromyalgia:
• Any other diagnosed medical condition known to contribute to
fibromyalgia symptomatology that is not under adequate control for the
study period such as thyroid disease, inflammatory arthritis, systemic
lupus erythematosus, rheumatoid arthritis, myositis, vasculitis and/or
Sjogren’s syndrome
(WPI ≥7 and SS ≥5) or (WPI 3–6 and SS ≥9) and does not have a disorder
that would otherwise explain the pain [36]
• Verbal confirmation of pregnancy or planned pregnancy within the trial
period
• Willing to complete the 12-week or 24-week study, including once- or
twice-a-week exercise sessions.
• Not English speaking
• Mini-Mental Status Examination score below 24 [38]
• Willing to abstain from Tai Chi or other new formalized exercise
programs until completion of the study if randomized to the aerobic
exercise intervention
• Inability to pass the Physical Activity Readiness Questionnaire (PAR-Q)
• Enrollment in any other clinical trial within the last 30 days
• Willing to abstain from aerobic exercise or other new formalized exercise
programs until completion of the study if randomized to Tai Chi
• Plan to permanently relocate from the region during the trial period
SS, symptom severity; WPI, widespread pain index.
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Combinations of advertising strategies that have been
found to be successful in prior recruitment initiatives for
rheumatology clinical trials are employed [23,25,26,32,39].
These strategies include flyers within the hospital and ad-
vertisements in the print and online media. To ensure ad-
equate enrollment of a diverse study population, including
under-represented groups, advertisements are placed in a
wide range of media outlets including Craigslist, the Tufts
Medical Center website, the Boston Metro and other
newspapers, The Fifty Plus newsletter, Clinicalconnection.
com and clinicaltrials.gov. Participants are also recruited
from the rheumatology clinic patient database at Tufts
Medical Center. To accomplish this, we obtained a Health
Insurance Portability and Accountability Act waiver to flag
the charts of patients with a billing code of fibromyalgia
who have attended the Rheumatology Clinic within the
last year, and approach them for participation.
Enrollment is aided by collaboration with the Newton-
Wellesley Hospital and MedVadis Research Corporation,
which allows staff to recruit participants through their
clinics and databases. Any interested respondents receive
information about the study and answer a brief, scripted
survey to determine their eligibility for the trial (Additional
file 1). This screening survey includes items whose predict-
ive values for fibromyalgia are known from population-
based data [2].
Enrollment and the informed consent process
Participants are enrolled in groups of 36 or more partici-
pants per cycle in order to ensure a full classroomsetting for the group intervention. In the 3-week period
prior to the start of the intervention period, we complete
the baseline assessments for a group of 40 to 50 pre-
screened participants in order to obtain an eligible co-
hort of participants to randomize. Once the groups of 36
have been filled, no more participants are enrolled. Prior
to any information being collected, the principal investi-
gator (CW) or study coordinator (AS) completes the in-
formed consent process. Each person who agrees to
participate provides informed consent. After providing
informed consent, the principal investigator or study
staff screen participants to confirm that potential partici-
pants meet the eligibility criteria listed in Table 2.
Clinical examination
Clinical tender point examinations are performed at the
baseline visit. Prior to treatment assignment, the study
rheumatologists (WFH and RK) assess the Tender Point
Count: the 18 tender points in total are examined ac-
cording to the standardized protocol [40]. The tender
point is a behavioral response measuring a participant’s
reaction to the tender point examination. Upon palpa-
tion at each tender point site, reactions are rated on a
10-point scale (0 = no tenderness, to 10 = patient un-
touchable/withdrawal without palpation). The tender
points are calculated for each participant by dividing the
total score by 18 to obtain an average score for each site.
Randomization
Randomization occurs after the baseline evaluation. The
study statistician (CHS) randomizes assignments using a
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[41]. These assignments are then sent to a study staff
member other than the study coordinator or principal
investigator, who puts them into sealed, opaque enve-
lopes with date and signature labels placed over the seals
of the envelopes. The study coordinator then contacts
eligible participants by phone, and confirms that each
one still wishes to participate in the study and is able to
make the time commitment to either intervention
group. Upon confirmation, the study coordinator opens
the consecutive randomization envelope and informs the
individuals of their group assignments. The study coord-
inator also informs the participants of the schedule for
their training sessions (including date and time).
Randomization envelopes are not opened unless a par-
ticipant meets eligibility criteria, completes the informed
consent, and undergoes a baseline assessment.
The study is conducted in six different cycles. Each
cycle consists of an aerobic exercise intervention group
and two of the four Tai Chi intervention groups. The Tai
Chi intervention groups are rotated through the six cy-
cles so that each one (12 or 24 weeks of supervised Tai
Chi, once or twice per week) occurs three times over the
course of the study. We use a factorial arrangement to
ensure that each of the three Tai Chi instructors con-
ducts each of the four treatments (Tai Chi once or twice
per week for each of 12 and 24 weeks) once during the
trial. This arrangement is subject to the constraints that
two sessions are given in each of the six cycles, that each
instructor teaches twice in each of the first three and last
three cycles, that no instructor teaches more than once
in any single cycle and that each treatment is given at
least once and no more than twice in the first three ses-
sions and in the last three sessions. Each instructor is
therefore idle for two of the six sessions. The design for
each of the four treatments (A, B, C and D) is listed in
Table 3. The instructors are randomly assigned to be I,
II or III, and each of the four treatments is randomly
assigned to be A, B, C or D. Each resulting group con-
sists of 12 patients, for a total of 36 patients participat-
ing in each cycle and 216 over the course of the six
cycles comprising the study.
Study intervention
The study interventions require complete assembly of
each study group per cycle, prior to initiation of treat-
ment. The maximum waiting time between the baselineTable 3 Factorial arrangement for instructors
Instructor Cycle 1 Cycle 2 Cycle 3 Cycle 4 Cycle 5 Cycle 6
I Tx A Tx B Tx C Tx D
II Tx C Tx D Tx B Tx A
III Tx D Tx A Tx B Tx Cevaluation and the initiation of the intervention is
3 weeks. Both Tai Chi and aerobic exercise groups run
concurrently to avoid seasonal influences on disease
severity.Tai Chi intervention
The participants randomized to Tai Chi will practice at
Tufts Medical Center. A detailed description of a stan-
dardized Tai Chi protocol was prepared and tested in
our previous trials [23,25,26,32,39]. The three Tai Chi in-
structors each have extensive experience (>20 years)
conducting Tai Chi mind-body programs and follow a
Tai Chi protocol specifically designed for individuals
with chronic pain. In addition, all three instructors com-
pleted the required research and human subject protec-
tion training prior to initiation of the intervention
classes.
To ensure that instructors are prepared to teach a ro-
bust, standardized Yang-style Tai Chi treatment program
for patients with fibromyalgia, we conduct a training ses-
sion with the three Tai Chi instructors to thoroughly re-
view concepts of fibromyalgia and a standardized
teaching protocol at the beginning of the study and are
doing reviews as needed throughout the course of the
study. All sessions are monitored by regularly reviewing
video recordings and providing feedback throughout the
study to ensure proper instruction.
Each Tai Chi session lasts 60 minutes and continues
once or twice a week for 12 weeks or 24 weeks. Partici-
pants are also provided with printed materials on the Tai
Chi Mind-Body program, including Tai Chi principles,
practicing techniques, and safety precautions for partici-
pants with fibromyalgia. In the first session, the Tai Chi
instructor explains exercise theory and Tai Chi proce-
dures. For the remaining sessions, the procedures in-
clude the following components: (1) warm-up and a
review of Tai Chi principles and techniques; (2) Tai Chi
movement; (3) breathing techniques; and (4) various re-
laxation methods. All program components are derived
from classical Yang style Tai Chi 108 postures [42]. Due
to time limitations [22] we condensed the 108 postures
of Classical Yang style Tai Chi to 10 forms that could be
learned by participants with a chronic pain condition
within 12 or 24 weeks. The 10 forms were selected be-
cause: (1) they are easily comprehensible; (2) clearly rep-
resent progressive degrees of stress to postural stability,
with weight bearing moving from bilateral to unilateral
supports; and (3) seem to emphasize increasing magni-
tude of trunk and arm rotation with diminishing base of
support and, as such, will potentially improve physical
function without excessively stressing the joints. An
outline of the Tai Chi exercise program is shown in
Additional file 2.
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physical activities but to perform no new additional
strength training other than their Tai Chi exercises. Par-
ticipants are also instructed to practice Tai Chi for at
least 30 minutes per day at home. Tai Chi instructors re-
mind participants in class to practice daily according to
weekly assignments of Tai Chi poses. The data collected
for class attendance are recorded and verified using
standard case report forms that include a participant
sign-in sheet as well as a staff-completed attendance
sheet to confirm accurate attendance recordings.
After completing the 12 or 24 week treatment ses-
sions, participants are asked to continue with their exer-
cises. The research team monitors these participants
once a month with home calls until the 52-week follow-
up evaluations. All participants are asked to record their
exercise behavior until the end of 52 weeks. This is the
same for the aerobic exercise group, described below.
Aerobic exercise training
Participants randomized to aerobic exercise receive a
closely supervised, group-format cardiovascular (aerobic)
exercise program located on our Tufts Campus. The
program is consistent with the current recommended
guidelines of moderate intensity exercises for fibromyal-
gia [8,9,21].
In the fibromyalgia population, lower levels of cardio-
vascular fitness and lower thresholds for post-exercise
muscle pain and fatigue are reported [2,3]. Compliance
may be compromised due to training that is too intense
or to a lack of supervision. Therefore, our program is in-
dividually tailored to each participant, closely supervised,
introduced in a progressive manner, and gradually in-
creased in volume and intensity to achieve the target of
moderate-intensity exercise. The senior scientist in exer-
cise physiology (RAF) has over 20 years experience in
conducting exercise trials, oversees the program and
runs training sessions for the exercise instructors at
study initiation and throughout the trial. The experi-
enced instructors perform the exercise regimen. Each
session lasts 60 minutes, twice a week, for 24 weeks. We
instruct participants to walk daily on their own, grad-
ually increasing their time until they reach 30 minutes a
day. We also provide the participants with printed mate-
rials on fibromyalgia and the aerobic exercise program,
including aerobic exercise principles, practicing tech-
niques, and safety precautions for participants with
fibromyalgia.
In the first session, an instructor explains exercise the-
ory and procedures for fibromyalgia. In subsequent ses-
sions, all participants undergo a gradual progression
(that is, increased duration of activity and intensity of
exercise). Each session includes: (1) an active warm-up
including self-paced walking and stretching and a reviewof progression; (2) aerobic activity; and (3) cool-down
session involving active and static stretching exercises
with primary body movements. During the first week,
participants complete a 15-minute warm-up, 20 minutes
of aerobic training (50 to 60% estimated maximum heart
rate: Rated Perceived Exertion 11–13) [21], and 25 -
minute cool-down. Specifically, the anticipated progres-
sion includes increasing the duration of the aerobic
activity by 5 minutes every 2 weeks with minor changes
in the intensity as the duration is progressed. The pre-
cise progression is monitored by the instructors to en-
sure optimal progression for the group. By week 10 to
12, the session reaches 40 minutes of aerobic training
(60 to 70% estimated maximum heart rate). In the cool-
down session, the instructors also ensure participant
comfort and safety.
All participants are encouraged to maintain their usual
physical activities, but to perform no Tai Chi or other
new formalized exercise program. We track the reasons
for missed sessions and the number of missed sessions.
Note that all groups receive exercise logs/diaries to
complete during the studies, which are returned at the
12, 24 and 52 week evaluation visits. The data collected
for session attendance are recorded and verified using
standard case report forms completed by the staff on a
weekly basis. Throughout the follow up period the re-
search team monitors these participants once a month
with home calls until the 52-week follow-up evaluation.Concomitant treatment
Participants are able to continue routine medications
such as nonsteroidal anti-inflammatory drugs, acet-
aminophen, analgesics and antidepressants, and main-
tain their usual treatment visits with their primary care
physician or rheumatologist throughout the study. Par-
ticipants are not required to wash out their pain medica-
tions prior to the start of the study. The research staff
records any changes made to treatment but do not
change or recommend changes in medical therapy.Measurements
Fibromyalgia outcome measurements are drawn from the
key variables recommended by the new 2010 American
College of Rheumatology Criteria [36] and focus on
fibromyalgia symptom severity and body pain. We as-
sess physical, psychological, and psychosocial variables
for fibromyalgia that are well-documented in clinical
care and research [11]. Every participant is evaluated at
baseline (prior to starting either intervention), after
completing the intervention (12 or 24 weeks later), and
at 24-week and 52-week follow-ups (Table 1). Durabil-
ity assessments up to 52 weeks are informative for clin-
ical practice based on prior data.
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The primary outcome measure is change in the FIQR
score between baseline and 24 weeks. The FIQR is a
well-validated multidimensional instrument that mea-
sures participant-rated overall severity of fibromyalgia,
including intensity of pain, physical function, fatigue,
morning tiredness, depression, anxiety, job difficulty,
and overall well-being [35]. Each item is standardized on
a scale ranging from 0 to 10, with lower scores indicat-
ing more improvement or less negative impact. In
addition, FIQR is also assessed weekly during the inter-
vention period for all groups of participants as well as at
the 52-week time points as secondary outcomes.
Secondary outcomes
It is essential in fibromyalgia treatment studies to meas-
ure a wide spectrum of variables due to the complex na-
ture of fibromyalgia and the importance of seeking
subsets of responses in this study.
Psychological and psychosocial functioning measures
The Patient’s Global Assessment (Global Visual Analogue
Scale) is a visual analogue scale that measures the level
of fibromyalgia severity on a 10-point scale with 10
reflecting the most extreme severity and 0 reflecting no
severity.
Health Related Quality of Life assessments are made
using the Medical Outcome Study Short Form 36 Health
Survey (SF-36) [43]. The SF-36 is a self-administered,
36-item questionnaire that assesses the concepts of
physical functioning, role limitations due to physical
problems, social function, bodily pain, general mental
health, role limitations due to emotional problems, vital-
ity, and general health perceptions. Summary scores in-
clude physical function, mental function, and combined
total function. Scores range from 0 to 100, with higher
scores indicating better health status [44].
The Beck II Depression Inventory (BDI) is a 21-
question, validated, self-report instrument that measures
the severity of depressive symptoms. Higher scores re-
flect a greater degree of symptom severity [45].
The Pittsburgh Sleep Quality Index is an 11-item, vali-
dated, self-report questionnaire that measures sleep
quality. Lower scores are associated with better sleep
quality [46].
The Coping Strategies Questionnaire is a seven-item,
validated, self-report questionnaire assessing pain cop-
ing, consisting of six cognitive and one behavioral scale.
Higher scores reflect greater usage of coping strategies
[47].
The Hospital Anxiety and Depression Scale is a 14-
item, validated, self-report questionnaire that assesses
levels of depression and anxiety. Higher scores reflect
greater levels of anxiety and depression [48].The Perceived Stress Scale is the most widely used
psychological instrument for measuring the perception
of stress. The 10-item scale also includes a number of
direct queries about current levels of experienced stress.
For this instrument, higher scores reflect a greater de-
gree of symptom severity [49].
The Chronic Pain Self-Efficacy Scale is a modified ver-
sion of The Arthritis Self-Efficacy Scale that has been
validated for patients with chronic pain [50]. It contains
eight questions divided into three subscales (pain coping,
physical functioning, and coping with symptoms). The
score is obtained by means of a Likert scale with a range
of 0 to 10, where higher scores indicate better self-
efficacy.
The Medical Outcome Study Social Support Survey
assesses social support by using the Social Support for
Physical Activity Scale adapted from Cohen and col-
leagues [51]. It comprises 19 questions rated from 0 to 5
to assess the influences that family and friends have on
patients as they perform regular physical activity. Higher
scores reflect more perceived social support from these
individuals.
Outcome expectations are beliefs that carrying out a
specific behavior such as physical activity will lead to a
desired outcome. The brief, validated, outcome expecta-
tions scale [52] contains nine questions that ask about
physical and mental benefits and are used to assess out-
come expectations. Scores can range from 1 to 5, with 1
indicating low outcome expectations for the exercise
and 5 suggesting high outcome expectations. This ques-
tionnaire is used prior to randomization to assess the
outcome expectation for any exercise intervention. It is
also assessed after randomization prior to the first ses-
sion to assess the outcome expectation for the assigned
intervention.
Participants enrolled in the trial also complete seven
Participant-Reported Outcomes Measurement Informa-
tion System (PROMIS) static short-forms, version 1.0 in-
struments, including PROMIS Pain Impact (six items),
Physical Functioning (10 items), Emotional Distress-
Anxiety (seven items), Emotional Distress-Depression
(eight items), Sleep Disturbance (eight items), Health
Assessment Questionnaire (twenty-seven items) and Sat-
isfaction with Participation in Social Roles (seven items)
[53].
The Health Assessment Questionnaire, developed ori-
ginally at Stanford in the late 1970s to assess patients
with rheumatoid arthritis, has been validated in a broad
range of rheumatic and non-rheumatic disease popula-
tions [53-57]. It is a 20-item, self-report questionnaire
which measures functional status (disability). Higher
scores indicate greater disability.
The NEO Five-Factor Inventory is a validated 60-
item questionnaire that measures the five domains of
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scientiousness, extraversion, and openness [58]. It con-
sists of five 12-item, five-point Likert scales that
measure each of the domains. Higher subscores indi-
cate higher levels of each personality trait.
The Five Facet Mindfulness Questionnaire is a vali-
dated, 39-item questionnaire that measures five facets of
mindfulness: observe, describe, act aware, nonjudge, and
nonreact [59]. Participants answer each of the questions
on a five-point Likert scale with higher scores reflecting
higher mindfulness.
The Credibility/Expectancy Questionnaire is a vali-
dated, six-item instrument that assesses how believable,
convincing, and logical the treatment seems to the par-
ticipant as well as what improvements the participant
thinks will be achieved. This questionnaire has been
adapted to reflect the participant population of this
study. Higher scores reflect greater credibility and ex-
pectancy by the participant [60].
The Pre-Clinical Disability Questionnaire is an adapted
12-item, yes/no questionnaire that assesses whether par-
ticipants have changed the way or how often they do a
series of daily activities such as climb a flight of stairs or
carry groceries [61]. More positive answers reflect
greater preclinical disability.
The Community Health Activities Model Program for
Seniors is as Physical Activity Questionnaire for Older
Adults and a validated, 40-item questionnaire that mea-
sures weekly physical activity levels for older adults by
calculating caloric expenditure [62] and frequency of
various common exercises completed by older adults
such as swimming or walking. Higher scores reflect
greater physical activity levels.
Physical function performance
Physical function assessments include the timed chair
stand, the 6-minute walk test, functional balance, and
lower extremity strength and power.
The timed chair stand tests measures time taken to
complete ten full stands from a sitting position and is a
reliable measure of lower body strength and dynamic
balance [63,64]. The recorded time is the average on two
attempts.
The 6-minute walk test is a reliable measure of func-
tional exercise capacity [65,66]. Participants are asked to
walk as fast and as far as possible within the 6-minute
period. Participants are given verbal encouragement
every minute throughout the 6 minutes and are in-
formed of the remaining time every minute. The dis-
tance in meters covered at the end is noted and
recorded.
One leg stand is defined as standing on one foot with-
out shoes with the contralateral knee bent and not
touching the weight bearing leg; the hips are level to theground. The test is conducted on the dominant and
nondominant leg with the eyes open and closed (four
conditions). We defined the dominant leg as the leg that
the participant said they would use to kick a ball.
The evaluator used a standardized script throughout
the assessment. If the participant is not comfortable per-
forming the single-leg stand test for any condition (for
example, eyes closed non-dominant leg) then they can
skip that part of the test. If the participant is comfortable
then they will first balance with their eyes open on their
dominant leg for 30 seconds or until the participant uses
their arms or opposite leg for support (for example, bra-
cing the nonweight-bearing leg against the weight-
bearing leg), or hops on the weight-bearing leg. The par-
ticipant will have up to five trials to reach 30 seconds.
Participants will take a 30-second break between trials
[67-70]. After completing the trials with eyes open and
on the dominant leg the participant will repeat these
steps for the three remaining conditions in a standard
order: 1) eyes open, nondominant leg; 2) eyes closed,
dominant leg; and 3) eyes closed nondominant leg.Measures of muscle strength/power
Participants’ muscle strength and power is measured
using a leg press. Participants are seated on the bilateral
leg press apparatus with knees flexed to 90 degrees and
hips flexed to approximately 110 degrees (Leg Press
A420, Keiser Corporation, Fresno, CA, USA). Knee
angle is measured using an electrogoniometer (AD In-
struments, Colorado Springs, CO, USA). Each partici-
pant is given the opportunity to familiarize themselves
with the testing equipment through the use of a visual
demonstration and practice at low resistances. Force,
position, and velocity of each repetition are sampled at
400 Hz and saved to disk for offline analysis. Using soft-
ware provided by the manufacturer, these data are then
converted to force, position and velocity at the footplate
(Software Release 7.8, Keiser Corporation). Leg extensor
muscle strength are quantitatively assessed using the
one-repetition maximum (1RM) technique and are de-
fined as the maximum load that could be moved only
once throughout the full range of motion (ROM) while
maintaining proper form [71]. Subjects perform the con-
centric phase, maintain full extension, and perform the
eccentric phase of each repetition over 2, 1, and 2 sec-
onds, respectively. After measurement of the 1RM, as-
sessment of leg press peak muscle power is made after a
5-minute rest period. Performance of this multiple at-
tempt peak power test has been previously described
and validated [71]. Briefly, each participant is instructed
to complete a total of five repetitions each separated by
30 seconds as quickly as possible through their full
ROM at both 70% and 40% of the 1RM. The highest
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power.
Accelerometry
Accelerometry allows objective measurement of physical
activity by the use of a motion sensor which records
both the number and magnitude of vertical accelerations
generated by human movement. This allows both vol-
ume and intensity of activity to be registered. In this
study, accelerometry measurements are performed using
the Actigraph Model 7164 (Manufacturing Technology
Inc., Pensacola, , FL, USA). The actigraph is worn super-
ior to the iliac crest in a custom pouch, secured to the
participant’s belt by a Velcro fastener. Participants are
instructed to wear the actigraph during the baseline and
follow-up visits for a consecutive 7-day period, excluding
sleep and bathing time. Activity is recorded using 1-
minute epochs and participants also complete a log to
record when the actigraph was worn.
Adherence
Our trained staff remind participants of home practice,
monitor adverse events, and ensure completion of exer-
cise logs/diaries. All participants are encouraged to
maintain their usual physical activities, but to perform
no new formalized exercise program. We track the num-
ber of missed sessions for each participant during the
intervention period. Participants’ attendance is moni-
tored during each in-person session (12 or 24 for Tai
Chi and 24 weeks for aerobic exercise) by staff-
completed attendance forms as well as class sign-in
sheets for the Tai Chi intervention. Participants are also
asked to maintain daily Tai Chi or aerobic exercise prac-
tice throughout the follow-up period and are encouraged
with phone calls from the research staff once a month
until the end of the 52 weeks using standardized ques-
tionnaires. Adherence is measured post-intervention by
these calls during which research staff ask about the fre-
quency and duration of the Tai Chi and aerobic exercise.
as well as which exercises were done by those partici-
pants in the aerobic exercise intervention.
Safety
Study participants are monitored weekly during the
study intervention for the occurrence of adverse events
defined as any undesirable experience. All adverse events
are recorded on an adverse event case report form dur-
ing study interventions and evaluated for relevance to
the intervention and severity according to institutional
review board mandated criteria by the study rheuma-
tologist. These are reported by category and are exam-
ined for trends that could indicate safety risk to the
participants with particular emphasis on serious adverse
events and any adverse events deemed related to theintervention. This plan has been approved by the Ethics
Review Board and the Data Safety Monitoring Board
(DSMB). All adverse events are reported to the Human
Research Committee promptly in accordance with
guidelines.
Plan for monitoring depression
We are using the BDI-II to screen, monitor, and analyze
depression The BDI is administered throughout the
study to monitor depressive symptoms in participants
(once a month during intervention, and then at each
follow-up visit). If an enrolled participant obtains a BDI
score >28, marking severe symptom severity during the
study, the study physician and primary investigator will
advise the individual to seek medical help outside of the
study. The intake telephone number to the Tufts Medical
Center outpatient psychiatry department is provided if
the individual requests a referral. It is important to
note that the BDI is being used to monitor depressive
symptoms which may influence compliance and out-
come of this study based on our extensive experience
from prior trials [35].
Data management
In accordance with our study protocol, we have exten-
sive procedures in place to ensure quality control of data
collection, data entry, and subject confidentiality. Study
data are to be collected and managed using the REDCap
electronic data capture system [72]. Participants who are
not able to directly enter data into the REDcap system
will be asked to fill out paper case report forms, which
are entered into REDCap by study staff. These case re-
port forms will then be filed in the participants’ file and
stored in the principal investigator or study coordinator’s
office in locked filing cabinets. No participant identifiers
are included in the study database. Data are exported
from the database into statistical software for analysis.
Additionally, REDCap has an audit trail that records
every time a participant or staff member makes changes
to any data entered on the website. All case report forms
are either collected in a REDCap Database, a secure on-
line database, or on paper record, which are kept in a se-
cure and lock-protected location. The primary outcome,
the FIQR, is measured by an initial staff member then
re-measured by a second staff member. In addition, the
measurement is entered into the REDCap Database by
an initial staff member then the data entry is double
checked by a second staff member. The statistician
(LLP) reviews the database to ensure accurate data col-
lection and correct data export for future analyses. The
data is read into SAS from REDCap and descriptive sta-
tistics are generated to check for missing data and to
check for out-of range values. The research staff main-
tains a log of all data entry procedures which includes
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sure proper data entry procedures. Extensive procedures
are in place to minimize missing data, including a data-
base that automatically flags any missing data when
subjects are completing questionnaires, double-checks
any data points and thoroughly checks every form
before participants leave their evaluation visits and
interventions.
Data and safety monitoring
We have established an National Institutes of Health-
approved independent DSMB. The DSMB team is com-
prised of investigators with expertise in rheumatology
clinical trials, statistical design, exercise, and adverse
events. Members of the DSMB do not have any affili-
ation with Tufts Medical Center. The DSMB is respon-
sible for monitoring the project, subject safety and
adequacy of data quality. We provide to the DSMB a
number of reports including serious adverse events or
death within 24 hours of knowledge of event occurrence,
annual reports of all adverse events as well as routine
progress reports prior to each DSMB meeting.
National Institute of Health site visits
The National Center for Complementary and Integrative
Health (NCCIH)/National Institute of Health initiated a
clinical site monitoring program for the trial. The site
monitoring has assisted both NCCIHand its investiga-
tors in fulfilling our mutual responsibilities of ensuring
participant safety, ensuring adherence of studies to ap-
plicable regulations, and verifying data quality, complete-
ness and accuracy. NCCIH expanded this monitoring
program across the portfolio, with the goal of imple-
menting routine initial site monitoring for most inter-
ventional studies as well as large observational projects.
The NCCIH Office of Clinical and Regulatory Affairs
established a contract for the NCCIH Clinical Studies
Monitoring Service with Westat, a Maryland-based con-
tract research organization. Westat staff conduct pre-
enrollment site visits for studies that are beginning en-
rollment and periodic interim site visits after enrollment
is initiated. The initial Westat represented NCCIHsite
visit convened on 14 March 2012. The site monitor es-
tablishes a guideline for monitoring the study periodic-
ally which includes review the protocol, informed
consent forms, case report forms, data and safety moni-
toring plans and data quality.
Sample size
We propose to enroll 216 participants, 144 in the Tai
Chi group and 72 in the aerobic exercise group. Power
analyses are based on hypothesized changes in FIQR
total scores. We used the outcomes of two previous ran-
domized trials to formulate expected effects. Bothstudies used education controls. The first study by Rooks
and colleagues [73] compared the effects of a 16-week
aerobic and flexibility exercise program with an educa-
tion group among 101 participants with fibromyalgia.
They found that the aerobic and flexibility exercise
group had a 7.9-point mean improvement in the Fibro-
myalgia Impact Questionnaire (FIQ), yielding an effect
size of 0.62. The second study, our pilot trial of 66 par-
ticipants with fibromyalgia, compared 12-weeks of Tai
Chi with a wellness education control [40]. We found an
18.4-point mean improvement in the FIQ score in the
Tai Chi group, yielding an effect size of 1.04. We
hypothesize that patients receiving Tai Chi will improve
more than those receiving aerobic exercise. Using a two-
sided hypothesis test at a 0.05 significance level with an
allocation ratio of 2:1, a total sample size of 216 (144 in
the Tai Chi group, 72 in the aerobic exercise group)
would give about 80% power to detect a conservative ef-
fect size of 0.4.
We also seek to elucidate how four different schedules
of dose and frequency might modify the impact of Tai
Chi. With 36 individuals per group, we would have 80%
power to detect an effect size of 0.67 between two of
these groups with a two-sided 0.05 level test. We will
also gain power from the additional individuals tested in
the other groups as well as from the blocking by
instructor.
Data analysis
The primary outcome (change in FIQR between baseline
and 24 weeks) will be compared between the five treat-
ment groups using intention-to-treat with a two-sided
significance level set at 5%. Participants who withdraw
will be treated as having no change from baseline at all
times after dropping out. The primary analysis will be a
mixed model analysis of variance adjusting for the ran-
dom blocking factor of instructor. If any characteristics
differ substantially at baseline, we will adjust for them in
a mixed-model regression analysis. To protect against
multiple comparisons, we will only evaluate between-
group differences if the overall effect of treatment is sig-
nificant. If so, we will examine the following contrasts:
1) Tai Chi (four groups) versus aerobic exercise; 2) Tai
Chi (12 weeks) versus Tai Chi (24 weeks); 3) Tai Chi
once per week versus Tai Chi twice per week; and 4)
interaction of number of treatments per week and length
of treatment. We will also examine whether treatment
effects differ by instructor.
Secondary analyses will examine change in FIQR from
baseline to 12 and 52 weeks as well as secondary out-
comes for change at 12, 24, and 52 weeks. Continuous
outcomes will be compared by linear regression, and
discrete outcomes by logistic regression. All analyses will
follow the template for the primary outcome in the
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ment for instructor examining treatment duration and
frequency. If the instructor effect is not significant, we
will present results summarized across instructors. All
regression models will be assessed by regression diag-
nostics for adherence to model assumptions. To explore
potential psychological and psychosocial mediators (for
example, depression, self-efficacy, social support) that
may be useful in future research, we will examine treat-
ment interactions with a list of pre-defined moderators.
To control for multiple testing, we will perform these
tests at a conservative significance level adjusted for the
number of moderators tested. In addition, we will also
perform longitudinal analyses in which measurements at
baseline, 12, 24, and 52 weeks are jointly analyzed using
appropriate mixed models including time as a categor-
ical fixed factor with random intercepts and first-order
autocorrelation of the errors. Similar mixed models will
be used to examine the weekly FIQR measurements
taken in the intervention period. We will also check for
potential confounding and interaction between time,
treatment, instructor and other significant covariates. In
addition to intent-to-treat analyses in which dropouts
are treated as having no effect, we will also perform sec-
ondary analyses using multiple imputation and checks of
the mechanism by which participants drop out to deter-
mine whether ignorable or nonignorable missing data
methods are required [74,75]. If nonignorable methods
are needed, we will explore both selection and pattern-
mixture types [74,75].
Discussion
In this project, we are conducting the first randomized
comparative effectiveness trial of Tai Chi versus aerobic
exercise in a large fibromyalgia population with long-
term follow-up. We present here the plan for a robust
and well-designed trial to determine the optimal fre-
quency and duration of a supervised Tai Chi interven-
tion in relation to short- and long-term effectiveness.
Emerging evidence suggests that Tai Chi mind-body ex-
ercise has potential therapeutic benefits for fibromyalgia.
Specifically, prior studies have shown that 12 weeks
(once to twice per week) of Tai Chi or aerobic exercise is
the minimum intervention and practical length needed
to achieve effective benefits, especially among beginners
[13,14,22,23,26,40]. Further, patients with fibromyalgia
have also benefited from 24 weeks of Tai Chi but it is
unclear if this longer duration offers better results than a
12-week program.
Hence, the optimum dose and length (frequency or
duration) of supervised Tai Chi practice as a treatment
for fibromyalgia have not yet been conclusively deter-
mined. Optimal clinical implementation remains un-
known. In this study, we are comparing 12 weeks ofsupervised Tai Chi versus 24 weeks of supervised Tai
Chi, at two frequencies (one or two times per week), to
determine the optimal dose and length of supervised Tai
Chi needed for clinical application, compared to
24 weeks of supervised aerobic exercise. We propose to
determine the effectiveness of Tai Chi exercise compared
to aerobic exercise as well as its clinical utility in a larger
scale study over a longer period of time. In addition,
testing durability of the supervised exercise up to
52 weeks based on prior data will provide much needed
treatment information.
Moreover, investigating multiple secondary outcomes
will elucidate the potential mechanisms of mind-body ef-
fects. To address one of the unanswered questions from
our previous studies about whether the observed benefit
of Tai Chi was localized to the instruction of a single in-
structor or whether the observed benefit could be gener-
alized to others. Systematic differences across instructors
would imply that the amount of treatment benefit might
depend on the skill level of the individual instructor; lack
of differences would imply that the benefit might apply
more generally.
Thus, successful completion of the proposed study will
contribute to the evidence base of whether Tai Chi is
preferable to aerobic exercise as a simple, inexpensive,
effective, durable treatment for a major disabling disease
which incidentally decreases economic costs in the
healthcare system. Results of this study are expected to
have important public health implications for patients
with chronic pain.
Trial status
The study began in January 2012. Estimated trial com-
pletion is expected by June 2016.
Additional files
Additional file 1: Subject pre-screening interview.
Additional file 2: Instructions for Tai Chi instructors.
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